Inventor · disambiguated record
Qitao Xiao
Also filed as: XIAO QITAO
4 granted patents·5 pending applications·6 citations·filing 2016–2025
62Inventor score
Top patents by PatentIndex Score
9 records- 0192US11420970B1Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agentsNOVARTIS AG·Filed 2021·Granted Aug 23, 2022·5 cites·29 claims
- 0286US12312353B2Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agentsNOVARTIS AG·Filed 2022·Granted May 27, 2025·1 cites·20 claims
- 0372US2025276971A1Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agentsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0455US2025382621A1Immune effector cell therapies with enhanced efficacyNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0545US2022289732A1Heterocyclic wdr5 inhibitors as anti-cancer compoundsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0645US2019000880A1Immune effector cell therapies with enhanced efficacyMOTZ GREGORY·Filed 2016·Application pending·0 cites
- 0737US10604502B2Substituted 5-cyanoindole compounds and uses thereofNOVARTIS AG·Filed 2018·Granted Mar 31, 2020·0 cites·18 claims
- 0835US10590079B2Cyano-substituted indoles as LSD1 inhibitorsNOVARTIS AG·Filed 2017·Granted Mar 17, 2020·0 cites·16 claims
- 0935US2019298715A1Immune effector cell therapies with enhanced efficacyMOTZ GREGORY·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qitao Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →